Wistar Startup to Help Move Promising Immuno-Oncology Therapies into Clinic
News
The Wistar Institute has announced that it recently launched a startup, Immunaccel, to leverage proprietary technology, research infrastructure, and expertise to help its biotechology and pharmaceutical partners advance their lead immuno-oncology ... Read more